INDEPENDENT NEWS

FairJourney Biologics ‘future-proofs’ therapeutic antibody

Published: Tue 11 Dec 2018 10:22 AM
Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like molecules, has been selected by FairJourney Biologics, a leading contract research organization (CRO), to support the company’s growth as it incorporates increasingly large Sanger data sets and next-generation sequencing (NGS) into its discovery programs.
Geneious Biologics is Biomatters’ cloud-based enterprise software for analysis of antibodies and related constructs using DNA sequence data. The software applies intuitive visualization tools and advanced analytics to help specialist biologic drug development companies accelerate identification of therapeutic candidates.
Geneious Biologics was selected by FairJourney Biologics for its ability to automate analysis and quality control (QC) with accurate identification of relevant regions, sequence liabilities, errors and frame shifts.
“We are processing increasingly larger sets of antibody sequences,” said Daniela Teixeira, COO, FairJourney Biologics. “Geneious Biologics allows us to drill into huge antibody sequence sets and quickly identify where errors lie and inspect bad clones. This will ensure we return the most effective, stable therapeutic antibody candidates to our clients, faster.”
“We are excited that FairJourney Biologics is preparing for growth and future-proofing its discovery efforts with Geneious Biologics. There is a step change happening in the therapeutic antibody discovery industry as leading research enterprises like FairJourney Biologics leverage the power of high throughput antibody sequencing,” said Jannick Bendtsen, Vice President of Technology Services, Geneious Biologics.
“Our focus is building the world’s most robust and functional sequence analysis platform to help our customers deliver quicker, more accurate results and identify therapeutic antibody candidates faster.”

Next in Business, Science, and Tech

Trump authorises use of emergency crude stockpile
By: BusinessDesk
UK trade minister pops up into Wellington
By: BusinessDesk
UPDATE: Tamarind halts Tui drilling; OMV assesses options
By: BusinessDesk
Crown to seek clarity through appeal of High Court decision
By: New Zealand Government
Better safeguards for Commercial Video On-Demand viewers
By: New Zealand Government
Saudi attacks: Global oil prices spike, petrol uncertainty
By: RNZ
Q+A: Megan Woods interviewed by Jack Tame
By: TVNZ
MARKET CLOSE: NZ shares fall; high oil prices weigh
By: BusinessDesk
NZ dollar edges higher as concerns over Saudi attack ease
By: BusinessDesk
$US6.50 per Barrel increase for petrol
By: Gull Petroleum
Oiling for War: The Houthi Attack on Abqaiq
By: Binoy Kampmark
UK Trade Secretary holds trade talks in Beehive
By: RNZ
PM's Post-Cab 16/9/19: A Way Forward
By: The Scoop Team
NZ, UK ministers reiterate commitment to trade talks
By: New Zealand Government
UK International Trade Secretary visits New Zealand
By: UK Government
View as: DESKTOP | MOBILEWe're in BETA! Send Feedback © Scoop Media